Dr. Ronald R. Butendieck, MD

Dr. Butendieck practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Butendieck's NPI, 1114181047, was assigned on July 10, 2008. Dr. Butendieck graduated from University Of Florida College Of Medicine in 2008. Dr. Butendieck holds Florida license ME105119.

Dr. Butendieck's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Butendieck's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Butendieck practices. Vendor and product names are available with a free account.

Rheumatology is Dr. Butendieck's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Butendieck is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Butendieck's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, joint pain, lupus, muscle pain, fibromyalgia, and limb pain and rheumatoid arthritis among the conditions Dr. Butendieck treats.

CMS data shows 480 Medicare services from Dr. Butendieck across 8 procedure codes in 2024, for 365 Medicare patients. Medicare paid $37,362 for them.

CMS counts 365 Medicare patients who saw Dr. Butendieck in 2024. The largest group is 65 to 74, with 172 patients. 75% of them have arthritis, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Butendieck's median patient age at 60, with 59% women.

In 2024, Dr. Butendieck wrote 826 Medicare Part D claims for 218 patients. 77% of them were for generic drugs. CMS names the drug for 747 of them, across 20 drugs with 11 or more claims each, at $1,156,262 in total drug cost. In 2023, CMS named 604 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Butendieck for performance year 2024, reported as part of a group. Dr. Butendieck accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Butendieck as offering telehealth.

Dmand AI links 23 papers to Dr. Butendieck, published from 2010 to 2024. 2024 was the busiest year, with 5. The most frequent topics are Giant Cell Arteritis, Lupus Erythematosus, Systemic and Arthritis, Rheumatoid. Dr. Butendieck has published most often in J Rheumatol. Dr. Butendieck's most frequent co-authors are Andy Abril, MD, Florentina Berianu, MD and Sehreen Mumtaz, MD.

CMS Open Payments shows 208 general payments to Dr. Butendieck from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Novartis Pharmaceuticals Corporation paid the most, $4,341.

Dmand AI lists 1 award for Dr. Butendieck.

Dr. Butendieck graduated from University Of Florida College Of Medicine in 2008. Dr. Butendieck is a member of ACR.

Dr. Butendieck is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Aspirus Health Plan. POS plans come from the most carriers, 3. Check the plan with the practice before a visit.